Standout Papers

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa 2022 2026 2023 2024137
  1. Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa (2022)
    Ashlan J. Kunz Coyne, Amer El Ghali et al. Infectious Diseases and Therapy

Immediate Impact

4 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

Multidrug-resistant Gram-negative bacterial infections
2025 Standout
Framework Nucleic Acid-Based and Neutrophil-Based Nanoplatform Loading Baicalin with Targeted Drug Delivery for Anti-Inflammation Treatment
2025 Standout
2 intermediate papers

Works of Michael J. Rybak being referenced

Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections
2022
Emergence of Methicillin-Resistant Staphylococcus aureus with Intermediate Glycopeptide Resistance
2001
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael J. Rybak 264 152 165 153 18 565
Pamela M. Terry 293 182 220 125 12 599
Xiang Sun 211 63 268 244 23 543
Toyoji Okubo 245 87 216 289 29 578
Mikala Wang 171 70 222 141 30 589
P R Murray 369 63 90 176 15 629
S. Schaefler 223 78 112 278 18 582
L. D. Sabath 169 252 357 235 14 634
James Whiteaker 91 125 319 243 10 531
Olaniyi Ayobami 196 65 267 120 14 545
Lina P Carvajal 433 97 147 164 22 542

All Works

Loading papers...

Rankless by CCL
2026